Wordt geladen...
Optimization of the HA-1-specific T-cell receptor for gene therapy of hematologic malignancies
To broaden the applicability of adoptive T-cell therapy for the treatment of hematologic malignancies, we aim to start a clinical trial using HA-1-TCR transferred virus-specific T cells. TCRs directed against the minor histocompatibility antigen (MiHA) HA-1 are good candidates for TCR gene transfer...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Ferrata Storti Foundation
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3046283/ https://ncbi.nlm.nih.gov/pubmed/21109688 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2010.025916 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|